Todd Robert Nelson - 22 Jun 2023 Form 4 Insider Report for Telesis Bio Inc. (TBIO)

Reporting relationship: Chief Executive Officer, Director, 10%+ Owner
Issuer ticker: TBIO
Reported as of: 22 Jun 2023
Net transaction value: -$2,511
SEC form: 4
Accepted by SEC: 05 Mar 2024, 18:55:57 UTC
Prior SEC filing: 07 Jun 2023
Next SEC filing: 29 Feb 2024
Source filing: View source filing
Reporting owner signature: /s/ Rob Cutler, as Attorney-in-Fact

Key filing fact

Todd Robert Nelson filed Form 4 for Telesis Bio Inc. (TBIO) on 05 Mar 2024.

Key facts

This page summarizes Todd Robert Nelson's Form 4 filing for Telesis Bio Inc. (TBIO).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Mar 2024, 18:55.

Change

Previous filing in this sequence was filed on 07 Jun 2023.
Current net transaction value: -$2,511.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TBIO transaction

Common Stock

Award

Transaction value: $0
Shares: +47,700
Change %: +36%
Price: $0.000000
Shares after: 178,996
Date: 22 Jun 2023
Ownership: Direct
Footnotes: F1

TBIO transaction

Common Stock

Tax liability

Transaction value: $2,511
Shares: -4,756
Change %: -2.7%
Price: $0.5280
Shares after: 174,240
Date: 01 Mar 2024
Ownership: Direct
Footnotes: F2

TBIO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 6,000,000
Date: 22 Jun 2023
Ownership: See footnote
Footnotes: F3

TBIO holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 122,516
Date: 22 Jun 2023
Ownership: See footnote
Footnotes: F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TBIO transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +385,500
Change %
Price: $0.000000
Shares after: 385,500
Date: 22 Jun 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 385,500
Exercise price: $1.66
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. Subject to the Reporting Person's continuing as a Service Provider (as defined in the Issuer's 2021 Stock Incentive Plan (the "Plan")) through each applicable vesting date, 25% of the RSUs shall vest on each of March 1, 2024, March 1, 2025, March 1, 2026, and March 1, 2027.

Footnote F2

Represents the number of shares withheld by the Issuer to satisfy the tax withholding obligation in connection with the vesting of RSUs.

Footnote F3

Shares held of record by GATTACA Mining LLC ("GATTACA"). The Reporting Person is the managing member of GATTACA and may be deemed to have voting and dispositive power over the shares held by GATTACA.

Footnote F4

Shares held of record by M-185 Corporation ("M-185"). The Reporting Person is the majority owner of M-185 and may be deemed to have voting and dispositive power over the shares held by M-185.

Footnote F5

Subject to the Reporting Person's continuing as a Service Provider (as defined in the Plan) through each applicable vesting date, twenty-five percent (25%) of the shares subject to the option shall vest on March 1, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter.